Bionano Genomics (BNGO) Preferred Stock Liabilities (2017)
Bionano Genomics (BNGO) posted Preferred Stock Liabilities of $842845.0 for Q4 2017.
Bionano Genomics (BNGO) Preferred Stock Liabilities (2017) Analysis & Trends
Bionano Genomics has reported Preferred Stock Liabilities for 1 years, with the latest figure at $842845.0 in Q4 2017.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $842845.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $842845.0 (changed N/A YoY) and the FY2017 annual result came in at $842845.0, changed N/A from the prior year.
- Preferred Stock Liabilities held at $842845.0 in Q4 2017 per BNGO's latest filing.
- Over five years, Preferred Stock Liabilities peaked at $842845.0 in Q4 2017 and troughed at $842845.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 842,845.00 |